Recently, however, a SkM model derived from SOD1-mutant ALS patient hiPSCs exhibited delayed and lower rates of fusion, smaller myotube size, limited AChR expression, metabolic dysfunction, and significantly reduced force production compared to healthy cells (Badu-Mensah et al., 2020). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.